-+ 0.00%
-+ 0.00%
-+ 0.00%

HEPION PHARMACEUTICALS EXECUTES BINDING LETTER OF INTENT WITH NEW DAY DIAGNOSTICS TO COMMERCIALIZE DIAGNOSTIC TESTS FOR CELIAC DISEASE, RESPIRATORY MULTIPLEX, H. PYLORI AND HCC

Reuters·05/07/2025 12:30:25

Please log in to view news